Valuation: Ipsen

Market Cap 12.56B 14.06B 11.54B 10.48B 19.68B 1,332B 20.17B 138B 55.4B 703B 52.77B 51.64B 2,228B P/E 2026 *
11.1x
P/E 2027 * 12.6x
Enterprise Value 11.05B 12.37B 10.15B 9.22B 17.32B 1,172B 17.75B 121B 48.75B 619B 46.44B 45.44B 1,961B EV / Sales 2026 *
2.4x
EV / Sales 2027 * 2.12x
Free-Float
40.65%
Yield 2026 *
0.93%
Yield 2027 * 1.01%
1 day+0.78%
1 week+0.98%
Current month-2.03%
1 month+9.82%
3 months-1.59%
6 months-7.27%
Current year+29.75%
1 week 152.3
Extreme 152.3
159.1
1 month 138.6
Extreme 138.6
159.1
Current year 116
Extreme 116
174
1 year 115.6
Extreme 115.6
174
3 years 87.95
Extreme 87.95
174
5 years 77
Extreme 77
174
10 years 34.2
Extreme 34.2
174
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-30
Chief Executive Officer 57 2019-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 2005-08-29
Chairman 68 2010-11-21
Director/Board Member 69 2012-05-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/21/26 Buy

Director

500 0.0006%
9/8/26 Buy

Director

500 0.0006%
9/3/26 Sell

Director

-1,000 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+0.98%+24.42%+39.22% 14.06B
-0.11%+9.94%+57.20%+148.21% 1,255B
-1.62%-0.95%+42.90%+75.88% 641B
-0.98%-0.14%+34.93%+102.23% 505B
-0.04%-2.21%+47.73%+64.45% 381B
-2.49%+2.01%+75.38%+39.94% 357B
+0.85%+2.52%+30.55%+57.26% 303B
-0.51%+7.19%+9.21%+33.15% 286B
-0.90%+2.97%+55.67%+70.93% 249B
-1.68%+5.27%+37.21%+105.26% 208B
Average -0.30%+2.70%+41.52%+73.65% 419.93B
Weighted average by Cap. -0.19%+3.89%+46.64%+93.37%

Financials

2026 *2027 *
Net sales 4.6B 5.15B 4.23B 3.84B 7.21B 488B 7.39B 50.43B 20.29B 257B 19.32B 18.91B 816B 4.75B 5.31B 4.36B 3.96B 7.44B 503B 7.62B 52.05B 20.94B 266B 19.94B 19.52B 842B
Net income 1.14B 1.28B 1.05B 954M 1.79B 121B 1.84B 12.54B 5.05B 64.01B 4.81B 4.7B 203B 1.05B 1.18B 966M 878M 1.65B 112B 1.69B 11.53B 4.64B 58.87B 4.42B 4.32B 187B
Net Debt -1.51B -1.69B -1.39B -1.26B -2.36B -160B -2.42B -16.53B -6.65B -84.38B -6.33B -6.2B -267B -2.5B -2.79B -2.29B -2.08B -3.91B -265B -4.01B -27.37B -11.01B -140B -10.49B -10.26B -443B
Projected Income Statement - Annual - Ipsen
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
26-11-04 €154.40 +0.78% 8,944
26-11-03 €153.20 -1.42% 131,211
26-11-02 €155.40 -1.40% 100,524
26-10-30 €157.60 +1.16% 117,545
26-10-29 €155.80 +1.90% 88,649
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Ipsen
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
153.20EUR
Average target price
161.92EUR
Spread / Average Target
+5.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ipsen